ELI LILLY & Co
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 19/3024% above fair value
$1409.38−1.61 (-0.11%)
Close on Nov 3, 2026Market cap $1.33TP/E 45.7Yield 0.44%
Eli Lilly Outside U.S. foreign exchange impact YoY by Quarter
Outside U.S. foreign exchange impact YoY (%) (%)
Eli Lilly Outside U.S. foreign exchange impact YoY: 4.0% in Q2 2026, up 1.0 pts from a year earlier.
Latest, Q2 2026
4.0%
Period ended Jun 30, 2026
Change on a year earlier
+1.0 pts
3.0% in Q2 2025
History
30 quarters
Since Q1 2018
Sources
30
Documents cited below
Where the Q2 2026 figure comes from
“|| Foreign exchange rates | — | 4 | 1 | — | 7 | 2”
Source: Form 10-Q FY2026Q2 (filed 2026-08-05) ↗
Reported in Form 10-Q / 10-K MD&A & Form 8-K Q4 Releases.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Eli Lilly Outside U.S. foreign exchange impact YoY (%), quarterly Q1 2018–Q2 2026 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/rev-growth-nonus-fx
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.
See a number that looks wrong?